Recurrent Small-cell Lung Cancer (SCLC)

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB00112Bevacizumab2Completed1
DB01030Topotecan2Completed1